These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22427184)

  • 1. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Lim JS; Kim D; Baek SE; Myoung S; Choi J; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW; Keum KC
    Eur Radiol; 2012 Aug; 22(8):1693-700. PubMed ID: 22427184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
    Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
    Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Kim SH; Lee JM; Gupta SN; Han JK; Choi BI
    J Magn Reson Imaging; 2014 Sep; 40(3):730-7. PubMed ID: 24307571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH; Yu J; Wei Y; Wu JF; Xu Q
    J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
    Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
    Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer.
    Pham TT; Liney G; Wong K; Rai R; Lee M; Moses D; Henderson C; Lin M; Shin JS; Barton MB
    BMC Cancer; 2017 Jul; 17(1):465. PubMed ID: 28676107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
    Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Contrast-enhanced Magnetic Resonance Imaging Evaluation of Whole Tumour Perfusion Heterogeneity Predicts Distant Disease-free Survival in Locally Advanced Rectal Cancer.
    Pham TT; Wong K; Liney G; Lim S; Graham PL; Borok N; Truong MX; Rai R; Henderson C; Lee M; Barton MB
    Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):561-570. PubMed ID: 35738953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
    J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor re: Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Gollub MJ; Gultekin DH; Schwartz LH
    Eur Radiol; 2013 May; 23(5):1297-8. PubMed ID: 23179526
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of diffusion-weighted magnetic resonance imaging in prediction of the response to preoperative chemoradiotherapy in rectal carcinoma].
    Liang X; Zhang HM; Ye F; Ouyang H; Zhao XM; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):133-7. PubMed ID: 26899334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
    J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restaging of rectal cancer with hybrid positron emission tomography magnetic resonance imaging after preoperative chemoradiotherapy.
    Tey J; Tan JK; Tan KK; Soon YY; Loi HY; Mohamed JSA; Bakulbhai PA; Ang B; Liang TY
    Ann Acad Med Singap; 2023 Jun; 52(6):289-295. PubMed ID: 38904510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma.
    Kassam Z; Burgers K; Walsh JC; Lee TY; Leong HS; Fisher B
    Abdom Radiol (NY); 2019 Nov; 44(11):3641-3651. PubMed ID: 31327041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer.
    Pham TT; Liney G; Wong K; Henderson C; Rai R; Graham PL; Borok N; Truong MX; Lee M; Shin JS; Hudson M; Barton MB
    Phys Imaging Radiat Oncol; 2021 Apr; 18():26-33. PubMed ID: 34258404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.